704 related articles for article (PubMed ID: 29024353)
1. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list.
Duarte-Rojo A; Ruiz-Margáin A; Montaño-Loza AJ; Macías-Rodríguez RU; Ferrando A; Kim WR
Liver Transpl; 2018 Jan; 24(1):122-139. PubMed ID: 29024353
[TBL] [Abstract][Full Text] [Related]
2. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients.
Aby ES; Saab S
Clin Liver Dis; 2019 Nov; 23(4):589-605. PubMed ID: 31563213
[TBL] [Abstract][Full Text] [Related]
3. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis.
Brustia R; Savier E; Scatton O
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):205-215. PubMed ID: 29162460
[TBL] [Abstract][Full Text] [Related]
4. Nutrition and the transplant candidate.
Mazurak VC; Tandon P; Montano-Loza AJ
Liver Transpl; 2017 Nov; 23(11):1451-1464. PubMed ID: 29072825
[TBL] [Abstract][Full Text] [Related]
5. Frailty in advanced liver disease.
Laube R; Wang H; Park L; Heyman JK; Vidot H; Majumdar A; Strasser SI; McCaughan GW; Liu K
Liver Int; 2018 Dec; 38(12):2117-2128. PubMed ID: 29935102
[TBL] [Abstract][Full Text] [Related]
6. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.
Montano-Loza AJ
Minerva Gastroenterol Dietol; 2013 Jun; 59(2):173-86. PubMed ID: 23831908
[TBL] [Abstract][Full Text] [Related]
7. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC
Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
[TBL] [Abstract][Full Text] [Related]
8. Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes.
Idriss R; Hasse J; Wu T; Khan F; Saracino G; McKenna G; Testa G; Trotter J; Klintmalm G; Asrani SK
Liver Transpl; 2019 Feb; 25(2):217-227. PubMed ID: 30369002
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia in Chronic Liver Disease: Impact on Outcomes.
Ooi PH; Hager A; Mazurak VC; Dajani K; Bhargava R; Gilmour SM; Mager DR
Liver Transpl; 2019 Sep; 25(9):1422-1438. PubMed ID: 31242345
[TBL] [Abstract][Full Text] [Related]
10. Nutrition therapy: Integral part of liver transplant care.
Anastácio LR; Davisson Correia MI
World J Gastroenterol; 2016 Jan; 22(4):1513-22. PubMed ID: 26819518
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of sarcopenia in patients with cirrhosis.
Montano-Loza AJ
World J Gastroenterol; 2014 Jul; 20(25):8061-71. PubMed ID: 25009378
[TBL] [Abstract][Full Text] [Related]
12. Cause and management of muscle wasting in chronic liver disease.
Dasarathy S
Curr Opin Gastroenterol; 2016 May; 32(3):159-65. PubMed ID: 26974417
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia in end-stage liver disease and after liver transplantation.
Leunis S; Vandecruys M; Van Craenenbroeck AH; Cornelissen V; Bogaerts S; De Smet S; Monbaliu D
Acta Gastroenterol Belg; 2023; 86(2):323-334. PubMed ID: 37428166
[TBL] [Abstract][Full Text] [Related]
14. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant.
Saiman Y; Serper M
Clin Liver Dis; 2021 Feb; 25(1):35-51. PubMed ID: 33978582
[TBL] [Abstract][Full Text] [Related]
15. A mechanism based approach to management of children with end-stage liver disease.
Haafiz AB
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1085-1094. PubMed ID: 28803487
[TBL] [Abstract][Full Text] [Related]
16. Review article: impact of exercise on physical frailty in patients with chronic liver disease.
Williams FR; Berzigotti A; Lord JM; Lai JC; Armstrong MJ
Aliment Pharmacol Ther; 2019 Nov; 50(9):988-1000. PubMed ID: 31502264
[TBL] [Abstract][Full Text] [Related]
17. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?
Stirnimann G; Ebadi M; Tandon P; Montano-Loza AJ
Curr Gastroenterol Rep; 2018 Sep; 20(11):50. PubMed ID: 30259203
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in liver transplant candidates: frailty is a better indicator than severity of liver disease.
Derck JE; Thelen AE; Cron DC; Friedman JF; Gerebics AD; Englesbe MJ; Sonnenday CJ
Transplantation; 2015 Feb; 99(2):340-4. PubMed ID: 25606782
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality.
Aby ES; Lee E; Saggi SS; Viramontes MR; Grotts JF; Agopian VG; Busuttil RW; Saab S
J Clin Gastroenterol; 2019 Oct; 53(9):680-685. PubMed ID: 30180152
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia and Frailty in Cirrhosis: Assessment and Management.
Bunchorntavakul C
Med Clin North Am; 2023 May; 107(3):589-604. PubMed ID: 37001955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
